ATROPINE (AUTOINJECTOR) Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Atropine (autoinjector), and what generic alternatives are available?
Atropine (autoinjector) is a drug marketed by Rafa Labs Ltd and is included in one NDA.
The generic ingredient in ATROPINE (AUTOINJECTOR) is atropine. There are twenty-three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the atropine profile page.
Summary for ATROPINE (AUTOINJECTOR)
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Clinical Trials: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ATROPINE (AUTOINJECTOR) at DailyMed |
Recent Clinical Trials for ATROPINE (AUTOINJECTOR)
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
U.S. Army Space and Missile Defense Command | Phase 1 |
MicroDose Defense Products L.L.C. | Phase 1 |
University of Pittsburgh | Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for ATROPINE (AUTOINJECTOR)
US Patents and Regulatory Information for ATROPINE (AUTOINJECTOR)
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rafa Labs Ltd | ATROPINE (AUTOINJECTOR) | atropine | SOLUTION;INTRAMUSCULAR | 212319-001 | Jul 9, 2018 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |